In focus
Latest feed
Aardvark Therapeutics Shares Plummet as FDA Halts Crucial Prader-Willi Drug Trial
Neurocrine Biosciences: A Biotech Balancing Stable Growth with a Bold, Risky Bet
The Clock's Ticking: Harmony Biosciences, Wakix's Horizon, and the Path Ahead
Another Heartbreaking Setback in the Pursuit of Prader-Willi Syndrome Treatments
